Sagimet Biosciences (SGMT) Shares Issued (2023 - 2025)

Sagimet Biosciences (SGMT) recorded quarterly Shares Issued of -$25000.0 in Q4 2025, down 108.36% quarter-over-quarter from $299000.0 in Q3 2025.

Sagimet Biosciences (SGMT) Shares Issued (2023 - 2025) Analysis & Trends

Sagimet Biosciences' Shares Issued history runs 3 years deep, the most recent figure standing at -$25000.0 for Q4 2025.

In Q4 2025, Shares Issued changed N/A year-over-year to -$25000.0; the TTM figure through Dec 2025 stood at $274000.0 (up 140.35% YoY), while the FY2025 annual figure was $275000.0, up 141.23% from the prior year.
Shares Issued was -$25000.0 for Q4 2025 at Sagimet Biosciences, down from $299000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $299000.0 in Q3 2025 to a low of -$25000.0 in Q4 2025.
Historically, Shares Issued has averaged $78800.0 across 3 years, with a median of $14000.0 in 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	5.40 Mn
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	27.00 Mn
9	Abivax	91.71 Bn	91.71 Bn	-	26,927.15
10	Sagimet Biosciences	211.96 Mn	211.96 Mn	-	-

Download Data